Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

It's still early days for the company as it drives CGM to become the standard of care for all stages of insulin use. DexCom grew its user base by around 25% in 2024 to approximately 2.8 million to ...

The next-generation Control-IQ+ algorithm, used to enable automated insulin ... t:slim pump with Control-IQ+ technology to multiple daily injection regimens, with both groups using the Dexcom ...

They can pause or take the pump off for intermittent breaks, too. ViCentra designed 10 bright color options as well, giving customers a more personal choice. ViCentra launched its hybrid closed-loop ...